Literature DB >> 12731065

Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides.

Santiago Zelenay1, Fernanda Elías, Juan Fló.   

Abstract

Nucleic acid immunization is a new vaccination technology. DNA vaccines do not only carry the genetic information for the antigen of interest but also deliver an adjuvant effect due to the presence of immunostimulatory sequences within the plasmid backbone. It is generally assumed that the adjuvant properties of plasmid DNA are equal to those described for oligodeoxynucleotides (ODN) containing immunostimulatory CpG motifs. To challenge this hypothesis we have carried out a series of experiments comparing the ability of single- and double-stranded ODN containing CpG motifs to induce the activation of mouse spleen cells. Moreover, we compared the immunostimulatory properties of plasmids that were modified by the addition of two to four CpG motifs. Our results establish that plasmid DNA express their adjuvanticity as either double or single strands, and no differences were observed between modified and unmodified plasmids. On the other hand, the strongest stimulatory ODN sequences lost their adjuvant properties when administered as double-strand DNA. Furthermore, the profile of cytokines induced on spleen cells by plasmid DNA and ODN is different. Strikingly, plasmid DNA induces a moderate synthesis of IL-6 and a strong synthesis of IFN-gamma, whereas stimulation with ODN showed an inverse profile with a higher increase in the synthesis of IL-6 but a moderate increase in IFN-gamma. Finally, in vivo studies were consistent with the results obtained in vitro. Mice immunized with modified or unmodified plasmids encoding the glycoprotein D of HSV showed similar levels of cellular and humoral immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731065     DOI: 10.1002/eji.200323614

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo.

Authors:  Sven Klaschik; Debra Tross; Dennis M Klinman
Journal:  J Leukoc Biol       Date:  2009-01-29       Impact factor: 4.962

2.  Elucidation of the Mechanism of Increased Activity of Immunostimulatory DNA by the Formation of Polypod-like Structure.

Authors:  Kohta Mohri; Kengo Nagata; Shozo Ohtsuki; Shiori Toyama; Mao Nonomura; Yuki Takahashi; Yoshinobu Takakura; Makiya Nishikawa; Shinji Sakuma
Journal:  Pharm Res       Date:  2017-08-08       Impact factor: 4.200

3.  A DNA vaccine against Escherichia coli O157:H7.

Authors:  Kowsar Shariati Mehr; Seyed Latif Mousavi; Iraj Rasooli; Jafar Amani; Masoumeh Rajabi
Journal:  Iran Biomed J       Date:  2012

4.  Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteins.

Authors:  Travis S Hughes; Stephen J Langer; Kirk W Johnson; Raymond A Chavez; Linda R Watkins; Erin D Milligan; Leslie A Leinwand
Journal:  Mol Ther       Date:  2008-10-21       Impact factor: 11.454

5.  Immunological analysis of a Lactococcus lactis-based DNA vaccine expressing HIV gp120.

Authors:  Gregers J Gram; Anders Fomsgaard; Mette Thorn; Søren M Madsen; Jacob Glenting
Journal:  Genet Vaccines Ther       Date:  2007-01-29

Review 6.  Sensors of Infection: Viral Nucleic Acid PRRs in Fish.

Authors:  Sarah Poynter; Graeme Lisser; Andrea Monjo; Stephanie DeWitte-Orr
Journal:  Biology (Basel)       Date:  2015-07-08

7.  CRISPR/Cas9-loaded stealth liposomes effectively cleared established HPV16-driven tumours in syngeneic mice.

Authors:  Luqman Jubair; Alfred K Lam; Sora Fallaha; Nigel A J McMillan
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

8.  A DNA vaccine against tuberculosis based on the 65 kDa heat-shock protein differentially activates human macrophages and dendritic cells.

Authors:  Luís H Franco; Pryscilla F Wowk; Célio L Silva; Ana P F Trombone; Arlete A M Coelho-Castelo; Constance Oliver; Maria C Jamur; Edson L Moretto; Vânia L D Bonato
Journal:  Genet Vaccines Ther       Date:  2008-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.